Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung

Maria Fe Medina, Gary P. Kobinger, John Rux, Medhi Gasmi, David J. Looney, Paul Bates, James M. Wilson

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Abstract

A human immunodeficiency virus (HIV)-based vector pseudotyped with the Ebola Zaire (EboZ) viral envelope glycoprotein (GP) was recently shown to transduce murine airway epithelia cells in vivo. In this study, the vector was further redesigned to improve gene transfer and also to increase safety. We used mutant EboZ envelopes for pseudotyping, which resulted in higher titers and increased transduction of airway cells in vivo compared to vectors pseudotyped with wild-type EboZ GP. As these envelopes lack regions associated with toxicity of the wild-type EboZ GP, they should also be safer to use for pseudotyping of lentiviral vectors. In addition, lentiviral vectors were created based on feline immunodeficiency virus and shown to have similar efficiency of transduction compared to HIV-based vectors. The creation of lentiviral vectors with highly engineered EboZ envelopes improved the performance of the system and should also increase its safety since only minimal regions of the EboZ envelope, which lack the toxic domain, are used.

Original languageEnglish (US)
Pages (from-to)777-789
Number of pages13
JournalMolecular Therapy
Volume8
Issue number5
DOIs
StatePublished - Nov 2003
Externally publishedYes

Keywords

  • Cystic fibrosis
  • Ebola Zaire glycoprotein envelope
  • Gene therapy
  • Pseudotyped lentiviral vectors

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung'. Together they form a unique fingerprint.

Cite this